Rongtai Health plans to use 250 million yuan of its own funds to jointly establish the Feike Rongtai Investment Fund Suzhou Partnership Enterprise Limited Partnership with Kane Capital and Shanghai Feike Investment Co., Ltd. The fund has a total committed capital of 500 million yuan, with Rongtai Health contributing 49.90%. This transaction constitutes a related-party transaction because Zhang Bo, a director and board secretary of the company, serves as a director at Kane Capital. The fund will focus on investing in strategic emerging sectors such as advanced manufacturing, high-end equipment, and smart hardware, prioritizing hard-tech projects that support intelligent manufacturing technology synergies and projects or enterprises in the new consumer sector.
Shanghai Rongtai Health TechCompany invests 250M yuan in a fund; impact depends on fund performance, which is uncertain.